Here, we demonstrate that oncoVV-AVL triggers metabolic competition in HCC by regulating the ACSS2/TFEB axis, simultaneously disrupting glucose utilization and coupling lipogenesis to autophagic flux. This evidence concerns the gene ACSS2 and hepatocellular carcinoma.